{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:20:29Z","timestamp":1788272429948,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073061"],"award-info":[{"award-number":["82073061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"DOI":"10.1007\/s12282-026-01902-y","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:47:40Z","timestamp":1785736060000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PTX3 induces the expression of PD-L1 and promotes breast cancer immune escape"],"prefix":"10.1007","author":[{"given":"Liyuan","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4106-5703","authenticated-orcid":false,"given":"Jing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"issue":"1","key":"1902_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang CH, Li N. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduct Target Ther. 2025;10(1):227.","journal-title":"Signal Transduct Target Ther"},{"key":"1902_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216726","volume":"588","author":"M Gao","year":"2024","unstructured":"Gao M, Shi J, Xiao X, Yao Y, Chen X, Wang B, et al. PD-1 regulation in immune homeostasis and immunotherapy. Cancer Lett. 2024;588:216726.","journal-title":"Cancer Lett"},{"issue":"1","key":"1902_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02176-8","volume":"23","author":"M Jin","year":"2024","unstructured":"Jin M, Fang J, Peng J, Wang X, Xing P, Jia K, et al. PD-1\/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies. Mol Cancer. 2024;23(1):266.","journal-title":"Mol Cancer"},{"key":"1902_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2020.07.004","volume":"38","author":"M de Miguel","year":"2020","unstructured":"de Miguel M, Calvo E. Clinical challenges of immune checkpoint inhibitors. Cancer Cell. 2020;38:326\u201333.","journal-title":"Cancer Cell"},{"key":"1902_CR5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nature14011","volume":"515","author":"RS Herbst","year":"2014","unstructured":"Herbst RS, Soria JC, Kowanetz M, Fine GD, Hamid O, Gordon MS, et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature. 2014;515:563\u20137.","journal-title":"Nature"},{"key":"1902_CR6","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191115","volume":"217","author":"L Du","year":"2020","unstructured":"Du L, Lee JH, Jiang H, Wang C, Wang S, Zheng Z, et al. Beta-catenin induces transcriptional expression of PDL1 to promote glioblastoma immune evasion. J Exp Med. 2020;217:e20191115.","journal-title":"J Exp Med"},{"key":"1902_CR7","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.immuni.2017.11.016","volume":"47","author":"MA Coelho","year":"2017","unstructured":"Coelho MA, de Carn\u00e9 Tr\u00e9cesson S, Rana S, Zecchin D, Moore C, Molina-Arcas M, et al. Oncogenic RAS signaling promotes tumor immunoresistance by stabilizing PD-L1 mRNA. Immunity. 2017;47:1083-1099.e6.","journal-title":"Immunity"},{"key":"1902_CR8","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.molcel.2021.03.037","volume":"81","author":"X Dai","year":"2021","unstructured":"Dai X, Bu X, Gao Y, Guo J, Hu J, Jiang C, et al. Energy status dictates PD-L1 protein abundance and antitumor immunity to enable checkpoint blockade. Mol Cell. 2021;81:2317-2331.e6.","journal-title":"Mol Cell"},{"issue":"10","key":"1902_CR9","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3724\/abbs.2024085","volume":"56","author":"M Cai","year":"2024","unstructured":"Cai M, Xu M, Yu D, Wang Q, Liu S. Posttranslational regulatory mechanism of PD-L1 in cancers and associated opportunities for novel small-molecule therapeutics. Acta Biochim Biophys Sin. 2024;56(10):1415\u201324.","journal-title":"Acta Biochim Biophys Sin"},{"key":"1902_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-immunol-030409-101305","volume":"28","author":"B Bottazzi","year":"2010","unstructured":"Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol. 2010;28:157\u201383.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"1902_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bbcan.2017.11.004","volume":"1869","author":"A Giacomini","year":"2018","unstructured":"Giacomini A, Ghedini GC, Presta M, et al. Long pentraxin 3: a novel multifaceted player in cancer. Biochim Biophys Acta Rev Cancer. 2018;1869(1):53\u201363.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1902_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315302","volume":"23","author":"M Bogdan","year":"2022","unstructured":"Bogdan M, Meca AD, Turcu-Stiolica A, Oancea CN, Kostici R, Surlin MV, et al. Insights into the relationship between pentraxin-3 and cancer. Int J Mol Sci. 2022;23:15302.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1902_CR13","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s12672-025-02983-5","volume":"16","author":"S Zhou","year":"2025","unstructured":"Zhou S, Li N, Haishaer D, Zhao H. PTX3 as a diagnostic and prognostic biomarker in lung adenocarcinoma: a comprehensive analysis. Discov Oncol. 2025;16(1):1158.","journal-title":"Discov Oncol"},{"issue":"16","key":"1902_CR14","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1158\/0008-5472.CAN-14-0369","volume":"74","author":"G Stallone","year":"2014","unstructured":"Stallone G, Cormio L, Netti GS, Infante B, Selvaggio O, Fino GD, et al. Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer. Cancer Res. 2014;74(16):4230\u20138.","journal-title":"Cancer Res"},{"issue":"22","key":"1902_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16223754","volume":"16","author":"H Jung","year":"2024","unstructured":"Jung H, Kang J, Han KM, Kim H. Prognostic value of pentraxin3 protein expression in human malignancies: a systematic review and meta-analysis. Cancers (Basel). 2024;16(22):3754.","journal-title":"Cancers (Basel)"},{"key":"1902_CR16","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1038\/s41388-019-0848-9","volume":"38","author":"M Rathore","year":"2019","unstructured":"Rathore M, Girard C, Ohanna M, Tichet M, Ben Jouira R, Garcia E, et al. Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)\/NF-B signaling pathway. Oncogene. 2019;38:5873\u201389.","journal-title":"Oncogene"},{"key":"1902_CR17","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1007\/s10238-023-01137-7","volume":"23","author":"D Li","year":"2023","unstructured":"Li D, Hao Z, Nan Y, Chen Y. Role of long pentraxin PTX3 in cancer. Clin Exp Med. 2023;23:4401\u201311.","journal-title":"Clin Exp Med"},{"issue":"1","key":"1902_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40164-023-00441-y","volume":"12","author":"A Giacomini","year":"2023","unstructured":"Giacomini A, Turati M, Grillo E, Rezzola S, Ghedini GC, Schuind AC, et al. The PTX3\/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer. Exp Hematol Oncol. 2023;12(1):82.","journal-title":"Exp Hematol Oncol"},{"key":"1902_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aah4674","volume":"10","author":"C Thomas","year":"2017","unstructured":"Thomas C, Henry W, Cuiffo BG, Collmann AY, Marangoni E, Benhamo V, et al. Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers. Sci Signal. 2017;10:eaah4674.","journal-title":"Sci Signal"},{"key":"1902_CR20","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.7150\/jca.39562","volume":"11","author":"X Cui","year":"2020","unstructured":"Cui X, Zhang H, Cao A, Cao L, Hu X. Cytokine TNF-\u03b1 promotes invasion and metastasis of gastric cancer by down-regulating Pentraxin3. J Cancer. 2020;11:1800\u20137.","journal-title":"J Cancer"},{"key":"1902_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092255","volume":"13","author":"R Ronca","year":"2021","unstructured":"Ronca R, Taranto S, Corsini M, Tobia C, Ravelli C, Rezzola S, et al. Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells. Cancers (Basel). 2021;13:2255.","journal-title":"Cancers (Basel)"},{"key":"1902_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091277","volume":"11","author":"S Matarazzo","year":"2019","unstructured":"Matarazzo S, Melocchi L, Rezzola S, Grillo E, Maccarinelli F, Giacomini A, et al. Long pentraxin-3 follows and modulates bladder cancer progression. Cancers (Basel). 2019;11:1277.","journal-title":"Cancers (Basel)"},{"key":"1902_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bbcan.2017.11.004","volume":"1869","author":"A Giacomini","year":"2018","unstructured":"Giacomini A, Ghedini GC, Presta M, Ronca R. Long pentraxin 3: a novel multifaceted player in cancer. Biochim Biophys Acta Rev Cancer. 2018;1869:53\u201363.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1902_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216957","volume":"593","author":"J Lun","year":"2024","unstructured":"Lun J, Zhang Y, Yu M, Zhai W, Zhu L, Liu H, et al. Circular RNA circHIPK2 inhibits colon cancer cells through miR-373-3p\/RGMA axis. Cancer Lett. 2024;593:216957.","journal-title":"Cancer Lett"},{"issue":"10","key":"1902_CR25","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3724\/abbs.2024090","volume":"56","author":"Y Wang","year":"2024","unstructured":"Wang Y, Lun J, Zhang Y, Yu M, Liu X, Guo J, et al. MiR-373-3p promotes aerobic glycolysis in colon cancer cells by targeting MFN2. Acta Biochim Biophys Sin. 2024;56(10):1498\u2013508.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"15","key":"1902_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2209435120","volume":"120","author":"Q Ma","year":"2023","unstructured":"Ma Q, Jiang H, Ma L, Zhao G, Xu Q, Guo D, et al. The moonlighting function of glycolytic enzyme enolase-1 promotes choline phospholipid metabolism and tumor cell proliferation. Proc Natl Acad Sci U S A. 2023;120(15):e2209435120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1902_CR27","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41556-025-01627-8","volume":"27","author":"Y Duan","year":"2025","unstructured":"Duan Y, Hu Z, Han P, Lei B, Wang S, Wang Z, et al. ADSL-generated fumarate binds and inhibits STING to promote tumour immune evasion. Nat Cell Biol. 2025;27(4):668\u201382.","journal-title":"Nat Cell Biol"},{"key":"1902_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217993","volume":"633","author":"J Lun","year":"2025","unstructured":"Lun J, Li X, Zhang R, Wang C, Qin Y, Li Y, et al. The IRE1\/XBP1-mediated upregulation of LMTK2 attenuates endoplasmic reticulum stress by enhancing autophagic activity. Cancer Lett. 2025;633:217993.","journal-title":"Cancer Lett"},{"issue":"467","key":"1902_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aam8855","volume":"10","author":"AE Karnoub","year":"2017","unstructured":"Karnoub AE, VanHook AM. Science signaling podcast for 21 February 2017: pentraxin-3 in basal-like breast cancer. Sci Signal. 2017;10(467):eaam8855.","journal-title":"Sci Signal"},{"key":"1902_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.149665","volume":"703","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang B, Cao W, Xu X. PTX3 activates POSTN and promotes the progression of glioblastoma via the MAPK\/ERK signalling axis. Biochem Biophys Res Commun. 2024;703:149665.","journal-title":"Biochem Biophys Res Commun"},{"issue":"30","key":"1902_CR31","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1038\/s41388-019-0848-9","volume":"38","author":"M Rathore","year":"2019","unstructured":"Rathore M, Girard C, Ohanna M, Tichet M, Ben Jouira R, Garcia E, et al. Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)\/NF-kappaB signaling pathway. Oncogene. 2019;38(30):5873\u201389.","journal-title":"Oncogene"},{"issue":"4","key":"1902_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1158\/2326-6066.CIR-13-0127","volume":"2","author":"EA Mittendorf","year":"2014","unstructured":"Mittendorf EA, Philips AV, Meric-Bernstam F, Qiao N, Wu Y, Harrington S, et al. PD-L1 expression in triple-negative breast cancer. Cancer Immunol Res. 2014;2(4):361\u201370.","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"1902_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mc.23471","volume":"62","author":"JM Pimentel","year":"2023","unstructured":"Pimentel JM, Zhou JY, Wu GS. Regulation of programmed death ligand 1 (PD-L1) expression by TNF-related apoptosis-inducing ligand (TRAIL) in triple-negative breast cancer cells. Mol Carcinog. 2023;62(2):135\u201344.","journal-title":"Mol Carcinog"},{"key":"1902_CR34","doi-asserted-by":"publisher","first-page":"1627084","DOI":"10.3389\/fimmu.2025.1627084","volume":"16","author":"Y Hong","year":"2025","unstructured":"Hong Y, Fu Y, Long Q. Post-translational governance of NF-kappaB in cancer immunity: mechanisms and therapeutic horizons. Front Immunol. 2025;16:1627084.","journal-title":"Front Immunol"},{"key":"1902_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1093558","volume":"14","author":"Y Cui","year":"2023","unstructured":"Cui Y, Shi J, Cui Y, Zhu Z, Zhu W. The relationship between autophagy and PD-L1 and their role in antitumor therapy. Front Immunol. 2023;14:1093558.","journal-title":"Front Immunol"},{"issue":"19","key":"1902_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199380","volume":"26","author":"C Maheshwari","year":"2025","unstructured":"Maheshwari C, Castiglioni A, Walusimbi U, Vidoni C, Ferraresi A, Dhanasekaran DN, et al. The biological role and clinical significance of BECLIN-1 in cancer. Int J Mol Sci. 2025;26(19):9380.","journal-title":"Int J Mol Sci"},{"key":"1902_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-981-15-0602-4_5","volume":"1206","author":"HD Xu","year":"2019","unstructured":"Xu HD, Qin ZH. Beclin 1, Bcl-2 and autophagy. Adv Exp Med Biol. 2019;1206:109\u201326.","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"1902_CR38","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.4161\/15548627.2014.981792","volume":"10","author":"C Xu","year":"2014","unstructured":"Xu C, Feng K, Zhao X, Huang S, Cheng Y, Qian L, et al. Regulation of autophagy by E3 ubiquitin ligase RNF216 through BECN1 ubiquitination. Autophagy. 2014;10(12):2239\u201350.","journal-title":"Autophagy"},{"issue":"1","key":"1902_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/biomedicines14010014","volume":"14","author":"DGD Costa","year":"2025","unstructured":"Costa DGD, Queiroz FR, Oliveira FS, et al. Pentraxin 3 as a modulator of miRNAs and extracellular vesicles release in triple-negative breast cancer cells. Biomedicines. 2025;14(1):14.","journal-title":"Biomedicines"},{"issue":"1","key":"1902_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.724","volume":"12","author":"YW Hsiao","year":"2022","unstructured":"Hsiao YW, Chi JY, Li CF, Chen LY, Chen YT, Liang HY, et al. Disruption of the pentraxin 3\/CD44 interaction as an efficient therapy for triple-negative breast cancers. Clin Transl Med. 2022;12(1):e724.","journal-title":"Clin Transl Med"},{"key":"1902_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112332","volume":"136","author":"H Xie","year":"2024","unstructured":"Xie H, Ruan G, Wei L, Zhang H, Shi J, Lin S, et al. Obesity-associated metabolic inflammation promotes triple-negative breast cancer progression through the interleukin-6\/STAT3\/pentraxin 3\/matrix metalloproteinase 7 axis. Int Immunopharmacol. 2024;136:112332.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"1902_CR42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3892\/etm.2024.12412","volume":"27","author":"J Wu","year":"2024","unstructured":"Wu J, Yang R, Ge H, Zhu Y, Liu S. PTX3 promotes breast cancer cell proliferation and metastasis by regulating PKC\u03b6breast cancer, pentraxin 3, protein kinase C\u03b6, proliferation, metastasis. Exp Ther Med. 2024;27(3):124.","journal-title":"Exp Ther Med"}],"updated-by":[{"DOI":"10.1007\/s12282-026-01910-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01902-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-026-01902-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-026-01902-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:50:25Z","timestamp":1788270625000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-026-01902-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":42,"alternative-id":["1902"],"URL":"https:\/\/doi.org\/10.1007\/s12282-026-01902-y","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to correct the keywords.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12282-026-01910-y","URL":"https:\/\/doi.org\/10.1007\/s12282-026-01910-y","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no conflict of interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}